OrthoPediatrics reiterates $262M-$266M 2026 revenue target as product innovation super cycle accelerates
Source: SeekingAlpha
2026-02-26 21:28:31 ET
More on OrthoPediatrics
- OrthoPediatrics Corp. (KIDS) Q4 2025 Earnings Call Transcript
- OrthoPediatrics sees FY25 revenue of $236.1M
- Seeking Alpha’s Quant Rating on OrthoPediatrics
- Historical earnings data for OrthoPediatrics
- Financial information for OrthoPediatrics
Read the full article on Seeking Alpha
For further details see:
OrthoPediatrics reiterates $262M–$266M 2026 revenue target as product innovation super cycle accelerates
OrthoPediatrics Corp.
NASDAQ: KIDS
KIDS Trading
3.45% G/L:
$18.455 Last:
59,626 Volume:
$17.78 Open:
KIDS Latest News
February 26, 2026 04:05:00 pm
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
KIDS Stock Data
$436,220,155
16,877,043
1.27%
40
N/A
Medical Equipment & Supplies
Healthcare
US
Warsaw
